Mobile

The use of Panobinostat, administered in combination with Velcade, Thalidomise and Dexamethasone, in subjects with relapsed and relapsed/refractory multiple myeloma

Mise à jour : Il y a 5 ans
Référence : EUCTR2012-000842-36

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

During the dose escalation phase, the purpose of the study is to determine the maximum tolerated dose (MTD) of panobinostat, administered in combination with VTD, in subjects with relapsed and relapsed/refractory multiple myeloma. In the dose expansion phase the purpose of the study is to estimate the response rate (partial response or better) within 16 cycles of VTD-pano at the RD identified in the dose escalation phase.

Critère d'inclusion

  • Multiple myeloma in the relapsed and relapsed/refractory stage

Liens